Discover our highlights and key takeaways from the Microbiology Society Annual Conference with our Editor, Martha Powell, who runs through some of our favorite talks.
Browsing: Disease Area > Viral
Two genetically-modified broadly-neutralizing antibodies have been demonstrated to elicit long-term protection against an HIV-like virus in rhesus macaques, with a Phase I clinical trial now underway.
A novel initiative is working to ensure that approximately 1 billion individuals are vaccinated against yellow fever across 27 African countries by 2026.
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.
Mylan N.V have announced they’ll be launching their third HIV combination in the US, following FDA approval of their once-daily treatment Symfi™.
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
A recent study has presented an accurate estimation of pregnancy outcomes associated with Zika infection in French territories in the Americas.